Conference Programme

INFRAFRONTIER Conference 2026

Explore the programme and get ready for an inspiring event filled with top speakers and engaging sessions!

INFRAFRONTIER CONFERENCE 2026

Over two days, the conference will follow a clear scientific progression, from computational foundations to translational implementation, structured into five thematic sessions:

With these sessions, we will examine the future role of computational disease models as complements to in vivo and in vitro systems: under what conditions can they enhance predictive power, improve translational relevance, and guide experimental design more efficiently? Where are the current limits (conceptual, technical, and biological) and which bottlenecks (data quality, interoperability, mechanistic interpretability, benchmarking, governance) must be overcome to move from promising prototypes to robust, actionable models?

Each session will feature *internationally recognised invited speakers+ as well as selected contributions from submitted abstracts. Several sessions will include interactive workshop elements and structured on-stage discussions, designed to surface critical disagreements, define shared benchmarks, and clarify what “success” should look like for in silico disease modeling. Both conference days will conclude with panel discussions focused on the most pressing bottlenecks and the most promising routes forward.

Fulll programme coming soon!

Scientific Programme Committee

Dr Ana Zarubica

more infoChief Operating Officer at Centre for Immunophenomics (CIPHE), Marseille (France).

Dr Anna Moles

more infoDirector of the Istituto di Biochimica e Biologia Cellulare CNR (IBBC-CNR), Naples (Italy).

Dr Lluis Montoliu

more infoDeputy Director at Biotecnology National Centre (CNB-CSIC), Madrid (Spain).

Dr Radislav Sedláček

more infoDirector of the Czech Centre for Phenogenomics, Vestec (Czechia).

Dr Yann Herault

more infoResearch Director at the French National Centre for Scientific Research (CNRS), Strasbourg (France).
Director of the Mouse Clinical Institute, (“Institute Clinique de la Souris”, MCI/ICS), Strasbourg (France).
Research Team Leader at the IGBMC, Strasbourg (France).

Prof Dr Johannes Beckers

more infoScientific Managing Director at INFRAFRONTIER ERIC, Munich (Germany).

Dr Michael Raess

more infoAdministrative Managing Director at INFRAFRONTIER ERIC, Munich (Germany).

Dr Asrar Ali Khan

more infoScientific Project Manager at INFRAFRONTIER ERIC, Munich (Germany).

Dalia Puig

more infoCommunications Officer at INFRAFRONTIER ERIC, Munich (Germany).

Do you have questions?

We’re here to help! Reach out to us at vasb@vasensebagvre.rh

This conference is financed through INFRAPLUS project‘s funding received from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101131669.

INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).